Bitterroot Bio

Biotech

Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2154Valeo Pharma Inc.—$787K
2155Falcon Therapeutics, Inc.—$700K
2156Mindset Pharma Inc.—$694K
2157Bitterroot Bio——
2158ASL Analytical, Inc.—$2.4M
2159NOVAZOI THERANOSTICS——
2160PSYENCE BIOMEDICAL LTD.—$2.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Sirp-alpha Fusion Polypeptides With Modified Fc Domainsapplication
  • Multivalent Sirp-alpha Fusion Polypeptidesapplication
  • Sirp-alpha Fusion Polypeptides With Modified Fc Domainsapplication
  • Sirp-alpha Fusion Polypeptides With Modified Fc Domainsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.